In a prospective observational study, we demonstrated that methylglyoxal (MG) is an early, sensitive, and specific marker for the identification of patients suffering from sepsis or septic shock, which is superior to established markers of inflammation and infection such as procalcitonin, C-reactive protein, and interleukin-6.7 The gene discussed is IL6; the disease is Sepsis.